Therapeutic Efficacy of Urethral Sphincter Injections of Platelet- Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency: A Proof-of-Concept Clinical Trial
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to investigate the efficacy of autologous platelet-rich plasma (PRP) in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) refractory to medical treatment. Methods: Thirty-five patients with SUI due to urodynamically proven ISD were prospectively enrolled. Five milliliters of PRP (2.5–5 times the platelet concentration in peripheral blood) was injected into the external sphincter at 5 sites; all patients received 4 injections at monthly intervals. The primary end-point was the change in SUI severity as assessed by a visual analogue scale (VAS of SUI). The secondary-endpoints were the Global Response Assessment score and changes in urodynamic parameters from baseline to 3 months after treatment. Results: The mean age of patients was 68.7±12 years; the median duration of SUI was 4 years. Five patients had neurogenic SUI, while 30 had nonneurogenic SUI (21 with postprostatectomy incontinence, 6 with previous radical cystectomy, and 3 with other etiologies). Complete dryness was achieved in 7 patients (20.0%) while moderate improvement was observed in 14 (40.0%). The mean VAS of SUI score decreased significantly from 6.57±1.89 to 3.77±2.41 after treatment. The abdominal leak point pressure (ALPP) increased significantly from 98.3±55.8 to 157.3±79.3 cm H2O. There was no increase of ALPP in neurogenic SUI and less increase of ALPP in patients with failed treatment outcomes. No perioperative adverse events or severe complications occurred. Conclusions: Urethral PRP injection is safe and effective in increasing urethral resistance and improving SUI. PRP could be an alternative treatment modality for male and female patients with moderate SUI due to nonneurogenic causes.
Abstract
Purpose: The aim of this study was to investigate the efficacy of autologous platelet-rich plasma (PRP) in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) refractory to medical treatment. Methods: Thirty-five patients with SUI due to urodynamically proven ISD were prospectively enrolled. Five milliliters of PRP (2.5–5 times the platelet concentration in peripheral blood) was injected into the external sphincter at 5 sites; all patients received 4 injections at monthly intervals. The primary end-point was the change in SUI severity as assessed by a visual analogue scale (VAS of SUI). The secondary-endpoints were the Global Response Assessment score and changes in urodynamic parameters from baseline to 3 months after treatment. Results: The mean age of patients was 68.7±12 years; the median duration of SUI was 4 years. Five patients had neurogenic SUI, while 30 had nonneurogenic SUI (21 with postprostatectomy incontinence, 6 with previous radical cystectomy, and 3 with other etiologies). Complete dryness was achieved in 7 patients (20.0%) while moderate improvement was observed in 14 (40.0%). The mean VAS of SUI score decreased significantly from 6.57±1.89 to 3.77±2.41 after treatment. The abdominal leak point pressure (ALPP) increased significantly from 98.3±55.8 to 157.3±79.3 cm H2O. There was no increase of ALPP in neurogenic SUI and less increase of ALPP in patients with failed treatment outcomes. No perioperative adverse events or severe complications occurred. Conclusions: Urethral PRP injection is safe and effective in increasing urethral resistance and improving SUI. PRP could be an alternative treatment modality for male and female patients with moderate SUI due to nonneurogenic causes.
참고문헌 (25)
- Abrams P, "The standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)
- Radadia KD, "Management of postradical prostatectomy urinary incontinence : a review", Urology, 113, pp.13~19 (2018)
- Myers JB, "Management options for sphincteric deficiency in adults with neurogenic bladder", Transl Androl Urol, 5, pp.145~157 (2016)
- Lukacz ES, "Urinary incontinence in women : a review", JAMA, 24(318), pp.1592~1604 (2017)
- Kretschmer A, "Evaluation and management of postprostatectomy incontinence : a systematic review of current literature", Eur Urol Focus, 2, pp.245~259 (2016)
- Liu HH, "Durability of retropubic suburethral sling procedure and predictors for successful treatment outcome in women with stress urinary incontinence", Urology, 131, pp.83~88 (2019)
- Angulo JC, "Systematic review and meta-analysis comparing Adjustable Transobturator Male System(ATOMS)and Adjustable Continence Therapy(ProACT)for male stress incontinence", PLoS One, 14, pp.e0225762~ (2019)
- Tutolo M, "Efficacy and safety of artificial urinary sphincter(AUS) : Results of a large multi-institutional cohort of patients with mid-term follow-up", Neurourol Urodyn, 38, pp.710~718 (2019)
- Kretschmer A, "Surgical treatment of male postprostatectomy incontinence : current concepts", Eur Urol Focus, 3, pp.364~376 (2017)
- Hillary CJ, "Regenerative medicine and injection therapies in stress urinary incontinence", Nat Rev Urol, 17, pp.151~161 (2020)
- Ireneusz O, "Current interventional management of male stress urinary incontinence following urological procedures", Cent European J Urol, 68, pp.340~347 (2015)
- Mussano F, "Cytokine, chemokine, and growth factor profile of platelet-rich plasma", Platelets, 27, pp.467~471 (2016)
- Etulain J, "Platelets in wound healing and regenerative medicine", Platelets, 29, pp.556~558 (2018)
- Roy S, "Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation", Wound Repair Regen, 19, pp.753~766 (2011)
- Wu Y, "Bone marrow-derived stem cells in wound healing : a review", Wound Repair Regen (2007)
- Kuffler DP, "Platelet-rich plasma and the elimination of neuropathic pain", Mol Neurobiol, 48, pp.315~332 (2013)
- Jhang JF, "Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis : a case control pilot study", Low Urin Tract Symptoms, 11, pp.O42~7 (2019)
- Jhang JF, "Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial", Neurourol Urodyn, 38, pp.703~709 (2019)
- Jiang YH, "Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment", PLoS One, 13, pp.e0190704~ (2018)
- Liggett PE, "Human autologous serum for the treatment of full-thickness macular holes. A preliminary study", Ophthalmology, 102, pp.1071~1076 (1995)
- Anitua E, "Plasma rich in growth factors : preliminary results of use in the preparation of future sites for implants", Int J Oral Maxillofac Implants, 14, pp.529~535 (1999)
- Burnouf T, "Human platelet lysate : replacing fetal bovine serum as a gold standard for human cell propagation", Biomaterials, 76, pp.371~387 (2016)
- Chuang FC, "Management of lower urinary tract dysfunction after radical hysterectomy with or without radiotherapy for uterine cervical cancer", J Formosan Med Assoc, 108, pp.619~626 (2009)
- Chen CJ, "Surgical results in women with detrusor underactivity and stress urinary incontinence undergoing suburethral sling procedure-Predictive factors for successful outcome", Low Urin Tract Symptoms, 12, pp.143~149 (2020)
- Chellini F, "Influence of platelet-rich and platelet-poor plasma on endogenous mechanisms of skeletal muscle repair", regeneration, 2019, pp.20, 683~